Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2010

Open Access 01-12-2010 | Original investigation

Modulation of TGF-β/BMP-6 expression and increased levels of circulating smooth muscle progenitor cells in a type I diabetes mouse model

Authors: Peter E Westerweel, Cindy TJ van Velthoven, Tri Q Nguyen, Krista den Ouden, Dominique PV de Kleijn, Marie Jose Goumans, Roel Goldschmeding, Marianne C Verhaar

Published in: Cardiovascular Diabetology | Issue 1/2010

Login to get access

Abstract

Background

Diabetic patients experience exaggerated intimal hyperplasia after endovascular procedures. Recently it has been shown that circulating smooth muscle progenitor cells (SPC) contribute to intimal hyperplasia. We hypothesized that SPC differentiation would be increased in diabetes and focused on modulation of TGF-β/BMP-6 signaling as potential underlying mechanism.

Methods

We isolated SPC from C57Bl/6 mice with streptozotocin-induced diabetes and controls. SPC differentiation was evaluated by immunofluorescent staining for αSMA and collagen Type I. SPC mRNA expression of TGF-β and BMP-6 was quantified using real-time PCR. Intima formation was assessed in cuffed femoral arteries. Homing of bone marrow derived cells to cuffed arterial segments was evaluated in animals transplanted with bone marrow from GFP-transgenic mice.

Results

We observed that SPC differentiation was accelerated and numeric outgrowth increased in diabetic animals (24.6 ± 8.8 vs 8.3 ± 1.9 per HPF after 10 days, p < 0.05). Quantitative real-time PCR showed increased expression of TGF-β and decreased expression of the BMP-6 in diabetic SPC. SPC were MAC-3 positive, indicative of monocytic lineage. Intima formation in cuffed arterial segments was increased in diabetic mice (intima/media ratio 0.68 ± 0.15 vs 0.29 ± 0.06, p < 0.05). In GFP-chimeric mice, bone marrow derived cells were observed in the neointima (4.4 ± 3.3 cells per section) and particularly in the adventitia (43.6 ± 9.3 cells per section). GFP-positive cells were in part MAC-3 positive, but rarely expressed α-SMA.

Conclusions

In conclusion, in a diabetic mouse model, SPC levels are increased and SPC TGF-β/BMP-6 expression is modulated. Altered TGF-β/BMP-6 expression is known to regulate smooth muscle cell differentiation and may facilitate SPC differentiation. This may contribute to exaggerated intimal hyperplasia in diabetes as bone marrow derived cells home to sites of neointima formation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brooks MM, Jones RH, Bach RG, Chaitman BR, Kern MJ, Orszulak TA, Follmann D, Sopko G, Blackstone EH, Califf RM: Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry. For the BARI Investigators. Circulation. 2000, 101: 2682-2689.CrossRefPubMed Brooks MM, Jones RH, Bach RG, Chaitman BR, Kern MJ, Orszulak TA, Follmann D, Sopko G, Blackstone EH, Califf RM: Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry. For the BARI Investigators. Circulation. 2000, 101: 2682-2689.CrossRefPubMed
2.
go back to reference Kornowski R, Mintz GS, Kent KM, Pichard AD, Satler LF, Bucher TA, Hong MK, Popma JJ, Leon MB: Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation. 1997, 95: 1366-1369.CrossRefPubMed Kornowski R, Mintz GS, Kent KM, Pichard AD, Satler LF, Bucher TA, Hong MK, Popma JJ, Leon MB: Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation. 1997, 95: 1366-1369.CrossRefPubMed
3.
go back to reference Tanaka K, Sata M, Hirata Y, Nagai R: Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res. 2003, 93: 783-790. 10.1161/01.RES.0000096651.13001.B4.CrossRefPubMed Tanaka K, Sata M, Hirata Y, Nagai R: Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res. 2003, 93: 783-790. 10.1161/01.RES.0000096651.13001.B4.CrossRefPubMed
4.
go back to reference Shoji M, Sata M, Fukuda D, Tanaka K, Sato T, Iso Y, Shibata M, Suzuki H, Koba S, Geshi E, Katagiri T: Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: Potential contribution of bone-marrow-derived progenitors to arterial remodeling. Cardiovasc Pathol. 2004, 13: 306-312. 10.1016/j.carpath.2004.08.004.CrossRefPubMed Shoji M, Sata M, Fukuda D, Tanaka K, Sato T, Iso Y, Shibata M, Suzuki H, Koba S, Geshi E, Katagiri T: Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: Potential contribution of bone-marrow-derived progenitors to arterial remodeling. Cardiovasc Pathol. 2004, 13: 306-312. 10.1016/j.carpath.2004.08.004.CrossRefPubMed
5.
go back to reference Cho HJ, Kim TY, Cho HJ, Park KW, Zhang SY, Kim JH, Kim SH, Hahn JY, Kang HJ, Park YB, Kim HS: The effect of stem cell mobilization by granulocyte-colony stimulating factor on neointimal hyperplasia and endothelial healing after vascular injury with bare-metal versus Paclitaxel-eluting stents. J Am Coll Cardiol. 2006, 48: 366-374. 10.1016/j.jacc.2005.12.080.CrossRefPubMed Cho HJ, Kim TY, Cho HJ, Park KW, Zhang SY, Kim JH, Kim SH, Hahn JY, Kang HJ, Park YB, Kim HS: The effect of stem cell mobilization by granulocyte-colony stimulating factor on neointimal hyperplasia and endothelial healing after vascular injury with bare-metal versus Paclitaxel-eluting stents. J Am Coll Cardiol. 2006, 48: 366-374. 10.1016/j.jacc.2005.12.080.CrossRefPubMed
6.
go back to reference Simper D, Stalboerger PG, Panetta CJ, Wang S, Caplice NM: Smooth muscle progenitor cells in human blood. Circulation. 2002, 106: 1199-1204. 10.1161/01.CIR.0000031525.61826.A8.CrossRefPubMed Simper D, Stalboerger PG, Panetta CJ, Wang S, Caplice NM: Smooth muscle progenitor cells in human blood. Circulation. 2002, 106: 1199-1204. 10.1161/01.CIR.0000031525.61826.A8.CrossRefPubMed
7.
go back to reference Kusuyama T, Omura T, Nishiya D, Enomoto S, Matsumoto R, Murata T, Takeuchi K, Yoshikawa J, Yoshiyama M: The Effects of HMG-CoA Reductase Inhibitor on Vascular Progenitor Cells. J Pharmacol Sci. 2006, 101: 344-349. 10.1254/jphs.FP0060102.CrossRefPubMed Kusuyama T, Omura T, Nishiya D, Enomoto S, Matsumoto R, Murata T, Takeuchi K, Yoshikawa J, Yoshiyama M: The Effects of HMG-CoA Reductase Inhibitor on Vascular Progenitor Cells. J Pharmacol Sci. 2006, 101: 344-349. 10.1254/jphs.FP0060102.CrossRefPubMed
8.
go back to reference Sugiyama S, Kugiyama K, Nakamura S, Kataoka K, Aikawa M, Shimizu K, Koide S, Mitchell RN, Ogawa H, Libby P: Characterization of smooth muscle-like cells in circulating human peripheral blood. Atherosclerosis. 2006, 187: 351-362. 10.1016/j.atherosclerosis.2005.09.014.CrossRefPubMed Sugiyama S, Kugiyama K, Nakamura S, Kataoka K, Aikawa M, Shimizu K, Koide S, Mitchell RN, Ogawa H, Libby P: Characterization of smooth muscle-like cells in circulating human peripheral blood. Atherosclerosis. 2006, 187: 351-362. 10.1016/j.atherosclerosis.2005.09.014.CrossRefPubMed
9.
go back to reference Nguyen TQ, Chon H, van Nieuwenhoven FA, Braam B, Verhaar MC, Goldschmeding R: Myofibroblast progenitor cells are increased in number in patients with type 1 diabetes and express less bone morphogenetic protein 6: a novel clue to adverse tissue remodelling?. Diabetologia. 2006, 49: 1039-1048. 10.1007/s00125-006-0172-0.CrossRefPubMed Nguyen TQ, Chon H, van Nieuwenhoven FA, Braam B, Verhaar MC, Goldschmeding R: Myofibroblast progenitor cells are increased in number in patients with type 1 diabetes and express less bone morphogenetic protein 6: a novel clue to adverse tissue remodelling?. Diabetologia. 2006, 49: 1039-1048. 10.1007/s00125-006-0172-0.CrossRefPubMed
10.
go back to reference Wilcox JN, Okamoto EI, Nakahara KI, Vinten-Johansen J: Perivascular responses after angioplasty which may contribute to postangioplasty restenosis: a role for circulating myofibroblast precursors?. Ann N Y Acad Sci. 2001, 947: 68-90. 10.1111/j.1749-6632.2001.tb03931.x.CrossRefPubMed Wilcox JN, Okamoto EI, Nakahara KI, Vinten-Johansen J: Perivascular responses after angioplasty which may contribute to postangioplasty restenosis: a role for circulating myofibroblast precursors?. Ann N Y Acad Sci. 2001, 947: 68-90. 10.1111/j.1749-6632.2001.tb03931.x.CrossRefPubMed
11.
go back to reference Biederman J, Yee J, Cortes P: Validation of internal control genes for gene expression analysis in diabetic glomerulosclerosis. Kidney Int. 2004, 66: 2308-2314. 10.1111/j.1523-1755.2004.66016.x.CrossRefPubMed Biederman J, Yee J, Cortes P: Validation of internal control genes for gene expression analysis in diabetic glomerulosclerosis. Kidney Int. 2004, 66: 2308-2314. 10.1111/j.1523-1755.2004.66016.x.CrossRefPubMed
12.
go back to reference Park SH, Marso SP, Zhou Z, Foroudi F, Topol EJ, Lincoff AM: Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus. Circulation. 2001, 104: 815-819. 10.1161/hc3301.092789.CrossRefPubMed Park SH, Marso SP, Zhou Z, Foroudi F, Topol EJ, Lincoff AM: Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus. Circulation. 2001, 104: 815-819. 10.1161/hc3301.092789.CrossRefPubMed
13.
go back to reference Jonas M, Edelman ER, Groothuis A, Baker AB, Seifert P, Rogers C: Vascular neointimal formation and signaling pathway activation in response to stent injury in insulin-resistant and diabetic animals. Circ Res. 2005, 97: 725-733. 10.1161/01.RES.0000183730.52908.C6.CrossRefPubMed Jonas M, Edelman ER, Groothuis A, Baker AB, Seifert P, Rogers C: Vascular neointimal formation and signaling pathway activation in response to stent injury in insulin-resistant and diabetic animals. Circ Res. 2005, 97: 725-733. 10.1161/01.RES.0000183730.52908.C6.CrossRefPubMed
14.
go back to reference Egashira K, Zhao Q, Kataoka C, Ohtani K, Usui M, Charo IF, Nishida K, Inoue S, Katoh M, Ichiki T, Takeshita A: Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys. Circ Res. 2002, 90: 1167-1172. 10.1161/01.RES.0000020561.03244.7E.CrossRefPubMed Egashira K, Zhao Q, Kataoka C, Ohtani K, Usui M, Charo IF, Nishida K, Inoue S, Katoh M, Ichiki T, Takeshita A: Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys. Circ Res. 2002, 90: 1167-1172. 10.1161/01.RES.0000020561.03244.7E.CrossRefPubMed
15.
go back to reference Moroi M, Zhang L, Yasuda T, Virmani R, Gold HK, Fishman MC, Huang PL: Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest. 1998, 101: 1225-1232. 10.1172/JCI1293.PubMedCentralCrossRefPubMed Moroi M, Zhang L, Yasuda T, Virmani R, Gold HK, Fishman MC, Huang PL: Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest. 1998, 101: 1225-1232. 10.1172/JCI1293.PubMedCentralCrossRefPubMed
16.
go back to reference Hillebrands JL, Klatter FA, van den Hurk BM, Popa ER, Nieuwenhuis P, Rozing J: Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest. 2001, 107: 1411-1422. 10.1172/JCI10233.PubMedCentralCrossRefPubMed Hillebrands JL, Klatter FA, van den Hurk BM, Popa ER, Nieuwenhuis P, Rozing J: Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest. 2001, 107: 1411-1422. 10.1172/JCI10233.PubMedCentralCrossRefPubMed
17.
go back to reference Saiura A, Sata M, Hirata Y, Nagai R, Makuuchi M: Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med. 2001, 7: 382-383. 10.1038/86394.CrossRefPubMed Saiura A, Sata M, Hirata Y, Nagai R, Makuuchi M: Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med. 2001, 7: 382-383. 10.1038/86394.CrossRefPubMed
18.
go back to reference Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R: Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002, 8: 403-409. 10.1038/nm0402-403.CrossRefPubMed Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R: Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002, 8: 403-409. 10.1038/nm0402-403.CrossRefPubMed
19.
go back to reference Liu C, Nath KA, Katusic ZS, Caplice NM: Smooth muscle progenitor cells in vascular disease. Trends Cardiovasc Med. 2004, 14: 288-293. 10.1016/j.tcm.2004.08.002.CrossRefPubMed Liu C, Nath KA, Katusic ZS, Caplice NM: Smooth muscle progenitor cells in vascular disease. Trends Cardiovasc Med. 2004, 14: 288-293. 10.1016/j.tcm.2004.08.002.CrossRefPubMed
20.
go back to reference Caplice NM, Bunch TJ, Stalboerger PG, Wang S, Simper D, Miller DV, Russell SJ, Litzow MR, Edwards WD: Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci USA. 2003, 100: 4754-4759. 10.1073/pnas.0730743100.PubMedCentralCrossRefPubMed Caplice NM, Bunch TJ, Stalboerger PG, Wang S, Simper D, Miller DV, Russell SJ, Litzow MR, Edwards WD: Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci USA. 2003, 100: 4754-4759. 10.1073/pnas.0730743100.PubMedCentralCrossRefPubMed
21.
go back to reference Sasaguri Y, Wang KY, Tanimoto A, Tsutsui M, Ueno H, Murata Y, Kohno Y, Yamada S, Ohtsu H: Role of histamine produced by bone marrow-derived vascular cells in pathogenesis of atherosclerosis. Circ Res. 2005, 96: 974-981. 10.1161/01.RES.0000166325.00383.ed.CrossRefPubMed Sasaguri Y, Wang KY, Tanimoto A, Tsutsui M, Ueno H, Murata Y, Kohno Y, Yamada S, Ohtsu H: Role of histamine produced by bone marrow-derived vascular cells in pathogenesis of atherosclerosis. Circ Res. 2005, 96: 974-981. 10.1161/01.RES.0000166325.00383.ed.CrossRefPubMed
22.
go back to reference Gill DS, Thompson CS, Dandona P: Histamine synthesis and catabolism in various tissues in diabetic rats. Metabolism. 1990, 39: 815-818. 10.1016/0026-0495(90)90124-U.CrossRefPubMed Gill DS, Thompson CS, Dandona P: Histamine synthesis and catabolism in various tissues in diabetic rats. Metabolism. 1990, 39: 815-818. 10.1016/0026-0495(90)90124-U.CrossRefPubMed
23.
go back to reference Blessing M, Schirmacher P, Kaiser S: Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions. J Cell Biol. 1996, 135: 227-239. 10.1083/jcb.135.1.227.CrossRefPubMed Blessing M, Schirmacher P, Kaiser S: Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions. J Cell Biol. 1996, 135: 227-239. 10.1083/jcb.135.1.227.CrossRefPubMed
24.
go back to reference Kaiser S, Schirmacher P, Philipp A, Protschka M, Moll I, Nicol K, Blessing M: Induction of bone morphogenetic protein-6 in skin wounds. Delayed reepitheliazation and scar formation in BMP-6 overexpressing transgenic mice. J Invest Dermatol. 1998, 111: 1145-1152. 10.1046/j.1523-1747.1998.00407.x.CrossRefPubMed Kaiser S, Schirmacher P, Philipp A, Protschka M, Moll I, Nicol K, Blessing M: Induction of bone morphogenetic protein-6 in skin wounds. Delayed reepitheliazation and scar formation in BMP-6 overexpressing transgenic mice. J Invest Dermatol. 1998, 111: 1145-1152. 10.1046/j.1523-1747.1998.00407.x.CrossRefPubMed
25.
go back to reference Gitelman SE, Kobrin MS, Ye JQ, Lopez AR, Lee A, Derynck R: Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo. J Cell Biol. 1994, 126: 1595-1609. 10.1083/jcb.126.6.1595.CrossRefPubMed Gitelman SE, Kobrin MS, Ye JQ, Lopez AR, Lee A, Derynck R: Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo. J Cell Biol. 1994, 126: 1595-1609. 10.1083/jcb.126.6.1595.CrossRefPubMed
26.
go back to reference Yang L, Scott PG, Giuffre J, Shankowsky HA, Ghahary A, Tredget EE: Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest. 2002, 82: 1183-1192.CrossRefPubMed Yang L, Scott PG, Giuffre J, Shankowsky HA, Ghahary A, Tredget EE: Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest. 2002, 82: 1183-1192.CrossRefPubMed
27.
go back to reference King KE, Iyemere VP, Weissberg PL, Shanahan CM: Kruppel-like factor 4 (KLF4/GKLF) is a target of bone morphogenetic proteins and transforming growth factor beta 1 in the regulation of vascular smooth muscle cell phenotype. J Biol Chem. 2003, 278: 11661-11669. 10.1074/jbc.M211337200.CrossRefPubMed King KE, Iyemere VP, Weissberg PL, Shanahan CM: Kruppel-like factor 4 (KLF4/GKLF) is a target of bone morphogenetic proteins and transforming growth factor beta 1 in the regulation of vascular smooth muscle cell phenotype. J Biol Chem. 2003, 278: 11661-11669. 10.1074/jbc.M211337200.CrossRefPubMed
28.
29.
go back to reference Peterson MC: Circulating transforming growth factor beta-1: a partial molecular explanation for associations between hypertension, diabetes, obesity, smoking and human disease involving fibrosis. Med Sci Monit. 2005, 11: RA229-RA232.PubMed Peterson MC: Circulating transforming growth factor beta-1: a partial molecular explanation for associations between hypertension, diabetes, obesity, smoking and human disease involving fibrosis. Med Sci Monit. 2005, 11: RA229-RA232.PubMed
30.
go back to reference Otsuka G, Agah R, Frutkin AD, Wight TN, Dichek DA: Transforming growth factor beta 1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways. Arterioscler Thromb Vasc Biol. 2006, 26: 737-743. 10.1161/01.ATV.0000201087.23877.e1.CrossRefPubMed Otsuka G, Agah R, Frutkin AD, Wight TN, Dichek DA: Transforming growth factor beta 1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways. Arterioscler Thromb Vasc Biol. 2006, 26: 737-743. 10.1161/01.ATV.0000201087.23877.e1.CrossRefPubMed
31.
go back to reference Ward MR, Agrotis A, Kanellakis P, Hall J, Jennings G, Bobik A: Tranilast prevents activation of transforming growth factor-beta system, leukocyte accumulation, and neointimal growth in porcine coronary arteries after stenting. Arterioscler Thromb Vasc Biol. 2002, 22: 940-948. 10.1161/01.ATV.0000019405.84384.9C.CrossRefPubMed Ward MR, Agrotis A, Kanellakis P, Hall J, Jennings G, Bobik A: Tranilast prevents activation of transforming growth factor-beta system, leukocyte accumulation, and neointimal growth in porcine coronary arteries after stenting. Arterioscler Thromb Vasc Biol. 2002, 22: 940-948. 10.1161/01.ATV.0000019405.84384.9C.CrossRefPubMed
32.
go back to reference Yamamoto K, Morishita R, Tomita N, Shimozato T, Nakagami H, Kikuchi A, Aoki M, Higaki J, Kaneda Y, Ogihara T: Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model: potential application of ribozyme strategy to treat cardiovascular disease. Circulation. 2000, 102: 1308-1314.CrossRefPubMed Yamamoto K, Morishita R, Tomita N, Shimozato T, Nakagami H, Kikuchi A, Aoki M, Higaki J, Kaneda Y, Ogihara T: Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model: potential application of ribozyme strategy to treat cardiovascular disease. Circulation. 2000, 102: 1308-1314.CrossRefPubMed
33.
go back to reference Bonnet F, Cao Z, Cooper ME, Cox AJ, Kelly DJ, Gilbert RE: Tranilast attenuates vascular hypertrophy, matrix accumulation and growth factor overexpression in experimental diabetes. Diabetes Metab. 2003, 29: 386-392. 10.1016/S1262-3636(07)70049-6.CrossRefPubMed Bonnet F, Cao Z, Cooper ME, Cox AJ, Kelly DJ, Gilbert RE: Tranilast attenuates vascular hypertrophy, matrix accumulation and growth factor overexpression in experimental diabetes. Diabetes Metab. 2003, 29: 386-392. 10.1016/S1262-3636(07)70049-6.CrossRefPubMed
34.
go back to reference Lee KM, Lee HJ, Kim MK, Kim HS, Jung GS, Hur SH, Kim HT, Cho WH, Kim JG, Kim BW, Lim JO, Choi HS, Lee KU, Park KG, Lee IK: Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injury. Atherosclerosis. 2009, 207: 391-398. 10.1016/j.atherosclerosis.2009.06.016.CrossRefPubMed Lee KM, Lee HJ, Kim MK, Kim HS, Jung GS, Hur SH, Kim HT, Cho WH, Kim JG, Kim BW, Lim JO, Choi HS, Lee KU, Park KG, Lee IK: Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injury. Atherosclerosis. 2009, 207: 391-398. 10.1016/j.atherosclerosis.2009.06.016.CrossRefPubMed
35.
go back to reference Bouvet C, Peeters W, Moreau S, DeBlois D, Moreau P: A new rat model of diabetic macrovascular complication. Cardiovasc Res. 2007, 73: 504-511. 10.1016/j.cardiores.2006.11.001.CrossRefPubMed Bouvet C, Peeters W, Moreau S, DeBlois D, Moreau P: A new rat model of diabetic macrovascular complication. Cardiovasc Res. 2007, 73: 504-511. 10.1016/j.cardiores.2006.11.001.CrossRefPubMed
36.
go back to reference Radovits T, Bomicke T, Kokeny G, Arif R, Loganathan S, Kecsan K, Korkmaz S, Barnucz E, Sandner P, Karck M, Szabo G: The phosphodiesterase-5 inhibitor vardenafil improves cardiovascular dysfunction in experimental diabetes mellitus. Br J Pharmacol. 2009, 156: 909-919. 10.1111/j.1476-5381.2008.00098.x.PubMedCentralCrossRefPubMed Radovits T, Bomicke T, Kokeny G, Arif R, Loganathan S, Kecsan K, Korkmaz S, Barnucz E, Sandner P, Karck M, Szabo G: The phosphodiesterase-5 inhibitor vardenafil improves cardiovascular dysfunction in experimental diabetes mellitus. Br J Pharmacol. 2009, 156: 909-919. 10.1111/j.1476-5381.2008.00098.x.PubMedCentralCrossRefPubMed
Metadata
Title
Modulation of TGF-β/BMP-6 expression and increased levels of circulating smooth muscle progenitor cells in a type I diabetes mouse model
Authors
Peter E Westerweel
Cindy TJ van Velthoven
Tri Q Nguyen
Krista den Ouden
Dominique PV de Kleijn
Marie Jose Goumans
Roel Goldschmeding
Marianne C Verhaar
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2010
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-9-55

Other articles of this Issue 1/2010

Cardiovascular Diabetology 1/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.